Objective: To evaluate the importance of molecular markers for prognosis and pathogenesis of endometrial carcinoma.
Design: Areview article.
Setting: Department of Medical Genetics and Fetal Medicine, University Hospital, Olomouc, Department of Obstetrics and Gynecology, University Hospital, Olomouc.
Methods: This article reviews the current knowledge of the molecular changes in the development of endometrial cancer, and their possible importance for the patient’s prognosis.
Conclusion: The new molecular biomarkers are apparently going to play asignificant role in the management of endometrial carcinoma treatment in the near future.
Key words: carcinoma, endometrium, marker, prognosis
THE FETAL MEDICINE CENTRE
Department of Obstetrics and Gynecology
Palacky University Olomouc, Faculty of Medicine and Dentistry
University Hospital Olomouc
I. P. Pavlova 6, 77520 Olomouc, Czech Republic
Tel: +420 585 852 785
Mobil: +420 606 220 644
E-mail: marek@lubusky.com
Web: www.lubusky.com